The Anti-Cardiolipin IgG (ACLA IgG) test is a blood test that detects specific autoantibodies associated with an increased risk of blood clots and pregnancy complications, primarily as part of diagnosing Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE). “ACLAM” is likely a typo and refers to the ACLA test (Anti-Cardiolipin Antibody)